Insider Decision: Roger E Susi Offloads $483K Worth Of iRadimed Stock

Roger E Susi, CEO at iRadimed (NASDAQ:IRMD), disclosed an insider sell on December 22, according to a recent SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Monday, Susi sold 5,000 shares of iRadimed. The total transaction value is $483,671. iRadimed shares are trading down 0.55% at $96.6 at the time of this writing on Tuesday morning. All You Need to Know About iRadimed iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States. iRadimed: Delving into Financials Revenue Growth: iRadimed displayed positive results in 3 months. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately 15.69%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers. Profitability Metrics: Gross Margin: The company excels with a remarkable gross margin of 77.8%, indicating superior cost efficiency and profitability compared to its industry peers. Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 0.44, iRadimed showcases strong earnings per share. Debt Management: With a below-average debt-to-equity ratio of 0.0, iRadimed adopts a prudent financial strategy, indicating a balanced approach to debt management. Valuation Metrics: A Closer Look Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 58.87, iRadimed's stock is perceived as being overvalued in the market. Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 15.49, iRadimed's stock is perceived as being overvalued in the market, particularly in relation to sales performance. EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an impressive EV/EBITDA ratio of 45.64, iRadimed demonstrates exemplary market valuation, surpassing industry averages. Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Unmasking the Significance of Insider Transactions Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction. Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise. Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors. The Insider's Guide to Important Transaction Codes Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company. Check Out The Full List Of iRadimed's Insider Trades. Insider Buying Alert: Profit from C-Suite Moves Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access. This article was generated by Benzinga's automated content engine and reviewed by an editor.